Capricor Therapeutics Inc. (CAPR) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Capricor Therapeutics Inc...

NASDAQ: CAPR · Real-Time Price · USD
7.09
0.57 (8.74%)
At close: Sep 26, 2025, 3:59 PM
7.14
0.70%
After-hours: Sep 26, 2025, 07:59 PM EDT

Capricor Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
11.29M 14.69M 9.6M 34.89M
Short-Term Investments
140.23M 24.79M 31.82M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
221.7K 268.17K 268.17K 275.72K
Receivables
10.37M 10.37M 547.58K 391.75K
Inventory
n/a n/a n/a n/a
Other Current Assets
1.5M 995.78K 919.89K n/a
Total Current Assets
163.39M 50.86M 42.89M 36.44M
Property-Plant & Equipment
6.87M 7.61M 6.94M 4.62M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
7.1M 7.88M 7.21M 4.89M
Total Assets
170.48M 58.73M 50.09M 41.33M
Account Payables
8.18M 6.22M 4.83M n/a
Deferred Revenue
12M 24.27M 17.98M n/a
Short-Term Debt
834.8K n/a n/a n/a
Other Current Liabilities
-824.8K n/a n/a 3.72M
Total Current Liabilities
21.03M 31.27M 23.59M 4.13M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
3.38M 3.38M 3.38M 3.38M
Total Long-Term Liabilities
3.99M 4.86M 14.72M 5.83M
Total Liabilities
25.02M 36.13M 38.31M 9.96M
Total Debt
1.45M 2.24M 2.56M 2.87M
Book Value
145.46M 22.6M 11.79M 31.37M
Book Value Per Share
4.13 0.84 0.48 1.36
Common Stock
45.58K 31.15K 25.24K 24.18K
Retained Earnings
-199.83M -159.37M -137.08M -108.06M
Comprehensive Income
1.03M 235.81K 105.24K n/a
Shareholders Equity
145.46M 22.6M 11.79M 31.37M
Total Investments
140.23M 24.79M 31.82M n/a